What New CDC Data and 2026 Guidance Mean for RSV Protection in Pregnancy
CDC and ACOG say families now have two main ways to protect babies from RSV: maternal vaccination during the right pregnancy window or an antibody product for the infant. New CDC surveillance suggests many babies still miss protection, often when clinicians do not clearly recommend it.
CDC and ACOG now frame RSV protection in pregnancy and early infancy as a practical choice between two main strategies. For many families, the most important step is simple: bring the topic up early at a prenatal or pediatric visit so the plan can be matched to the baby’s due date and the RSV season.
The newest CDC surveillance also suggests that protection is still uneven across the U.S. and that a clear recommendation from a clinician is closely tied to whether families get protected at all.
Two main ways to protect a baby
CDC says there are two ways to help keep a baby from getting very sick with RSV: a maternal RSV vaccine during weeks 32 through 36 of pregnancy, or an RSV immunization for an infant aged 8 months or younger during the baby’s first RSV season. CDC’s pregnancy vaccine guidance says the maternal option is seasonal, with vaccination during September through January.
CDC’s clinical guidance also notes that RSV monoclonal antibodies, including nirsevimab and clesrovimab, are recommended for infants, and nirsevimab is also used for some young children at increased risk.
What the new CDC data add
In CDC’s March 2026 RSVVaxView update, monthly estimates showed that infant protection by maternal vaccination or infant antibody receipt remains uneven. The surveillance page uses survey data rather than clinic records, so it is best read as a real-world implementation snapshot, not a perfect measure of coverage.
A related CDC MMWR report found that during the first season these products were recommended, maternal RSV vaccination coverage was 32.6% and infant nirsevimab coverage was 44.6% among the groups studied. The report also found that provider recommendation was strongly associated with higher uptake, and that lack of a recommendation was a major reason families did not get protection.
What ACOG adds for prenatal care
ACOG’s February 2026 maternal immunization guidance says obstetric clinicians should routinely assess vaccination status and recommend needed vaccines. In its RSV-specific materials, ACOG continues to emphasize the same basic idea as CDC: the right plan depends on gestational age, expected delivery timing, and whether the infant will receive an antibody product instead.
That matters because the two approaches are not usually something families need to pursue on their own without guidance. The goal is to choose the option that best fits the pregnancy timeline and the baby’s first RSV season.
What readers can ask at a visit
If you are pregnant or expecting a baby, reasonable questions include:
- Am I in the window for maternal RSV vaccination?
- How does my due date affect the timing?
- Is my baby likely to receive an RSV antibody product after birth instead?
- Does local RSV timing matter where I live?
Those questions are especially useful because CDC’s pregnancy guidance ties the maternal vaccine to a specific gestational window and seasonal period, while infant protection is timed to the baby’s own first RSV season.
The practical takeaway
Most families do not need to think about RSV protection as an all-or-nothing decision. They need a plan. For many people, the next step is simply to use the next prenatal or pediatric appointment to ask which option fits best and when it should happen.
If a baby is already born and has breathing trouble, poor feeding, or worsening symptoms during RSV season, that is a reason to contact a clinician promptly; severe breathing difficulty, blue lips, or signs of dehydration need urgent care.
Sources
Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.
This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.
